Autopsy report · NCT03626623

Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care

“Sponsor Discretion”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 9 months before it stopped.
• 15 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Integra LifeSciences Corporation

Sponsor type

Industry

Conditions

Diabetes; Diabetic Foot; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1

Interventions

Cytal Wound Matrix 1-Layer; Standard of Care (SOC)

Participants

15

Sites

3

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.